Gene · 5792
Papers2,345
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,345
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| HDAC inhibitors target IRS4 to enhance anti‑AR therapy in AR‑positive triple‑negative breast cancer. | Int J Oncol | 2024 | 38214343 | PubTator, text mining | PubMed |
| Optimising first-line subtyping-based therapy in triple-negative breast cancer (FUTURE-SUPER): a multi-cohort, randomised, phase 2 trial. | Lancet Oncol | 2024 | 38211606 | PubTator, text mining | PubMed |
| Pigment Diversity in Leaves of Caladium × hortulanum Birdsey and Transcriptomic and Metabolic Comparisons between Red and White Leaves. | Int J Mol Sci | 2024 | 38203776 | PubTator, text mining | PubMed |
| Mechanism of ferroptosis in breast cancer and research progress of natural compounds regulating ferroptosis. | J Cell Mol Med | 2024 | 38140764 | PubTator, text mining | PubMed |
| Estrogen receptor beta suppresses the androgen receptor oncogenic effects in triple-negative breast cancer. | Chin Med J (Engl) | 2024 | 38105538 | PubTator, text mining | PubMed |
| Pan-Cancer Single-Nucleus Total RNA Sequencing Using snHH-Seq. | Adv Sci (Weinh) | 2024 | 38010945 | PubTator, text mining | PubMed |
| Comparing mental health semi-structured diagnostic interviews and symptom checklists to predict poor life outcomes: an 8-year cohort study from childhood to young adulthood in Brazil. | Lancet Glob Health | 2024 | 37980914 | PubTator, text mining | PubMed |
| Functional Roles of CD133: More than Stemness Associated Factor Regulated by the Microenvironment. | Stem Cell Rev Rep | 2024 | 37922108 | PubTator, text mining | PubMed |
| Screening and validation of differentially expressed genes in adipose tissue of patients with obesity and type 2 diabetes mellitus. | Biomol Biomed | 2024 | 37597213 | PubTator, text mining | PubMed |
| Pathologic and immunohistochemical prognostic markers in residual triple-negative breast cancer after neoadjuvant chemotherapy. | Front Oncol | 2023 | 38273853 | PubTator, text mining | PubMed |
| Androgen Receptor in Hormone Receptor-Positive Breast Cancer. | Int J Mol Sci | 2023 | 38203649 | PubTator, text mining | PubMed |
| A ten long noncoding RNA-based prognostic risk model construction and mechanism study in the basal-like immune-suppressed subtype of triple-negative breast cancer. | Transl Cancer Res | 2023 | 38193005 | PubTator, text mining | PubMed |
| Combined RhoA morpholino and ChABC treatment protects identified lamprey neurons from retrograde apoptosis after spinal cord injury. | Front Cell Neurosci | 2023 | 38179205 | PubTator, text mining | PubMed |
| Multiomics insights on the onset, progression, and metastatic evolution of breast cancer. | Front Oncol | 2023 | 38169859 | PubTator, text mining | PubMed |
| TRPML1 as a potential therapeutic target for triple-negative breast cancer: a review. | Front Oncol | 2023 | 38156109 | PubTator, text mining | PubMed |
| MiR-199a-3p Regulates the PTPRF/β-Catenin Axis in Hair Follicle Development: Insights into the Pathogenic Mechanism of Alopecia Areata. | Int J Mol Sci | 2023 | 38139460 | PubTator, text mining | PubMed |
| Ca2+ Signaling and Src Functions in Tumor Cells. | Biomolecules | 2023 | 38136610 | PubTator, text mining | PubMed |
| Deep learning and transfer learning identify breast cancer survival subtypes from single-cell imaging data. | Commun Med (Lond) | 2023 | 38114659 | PubTator, text mining | PubMed |
| Strategic plan of the international association for child and adolescent psychiatry and allied professions (IACAPAP) for 2023-2026. | Child Adolesc Psychiatry Ment Health | 2023 | 38093393 | PubTator, text mining | PubMed |
| Cancer stem cell-immune cell crosstalk in breast tumor microenvironment: a determinant of therapeutic facet. | Front Immunol | 2023 | 38090567 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5792/papers?page=9